Recombinant Human TNFRSF1A Protein (Active) is a Human Fragment protein, in the 30 to 211 aa range, expressed in HEK 293, with >=95% purity, <= 0.005 EU/µg endotoxin level and suitable for SDS-PAGE, MS, Biological Activity, HPLC.
L V P H L G D R E K R D S V C P Q G K Y I H P Q N N S I C C T K C H K G T Y L Y N D C P G P G Q D T D C R E C E S G S F T A S E N H L R H C L S C S K C R K E M G Q V E I S S C T V D R D T V C G C R K N Q Y R H Y W S E N L F Q C F N C S L C L N G T V H L S C Q E K Q N T V C T C H A G F F L R E N E C V S C S N C K K S L E C T K L C L P Q I E N V K G T E D S G T T
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application MS | Reactivity Reacts | Dilution info - | Notes - |
Application Biological Activity | Reactivity Reacts | Dilution info - | Notes - |
Application HPLC | Reactivity Reacts | Dilution info - | Notes - |
Receptor for TNFSF2/TNF-alpha and homotrimeric TNFSF1/lymphotoxin-alpha. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Contributes to the induction of non-cytocidal TNF effects including anti-viral state and activation of the acid sphingomyelinase.
CD120a, TNFAR, TNFR1, TNFRSF1A, Tumor necrosis factor receptor superfamily member 1A, Tumor necrosis factor receptor 1, Tumor necrosis factor receptor type I, p55, p60, TNF-R1, TNF-RI, TNFR-I
Recombinant Human TNFRSF1A Protein (Active) is a Human Fragment protein, in the 30 to 211 aa range, expressed in HEK 293, with >=95% purity, <= 0.005 EU/µg endotoxin level and suitable for SDS-PAGE, MS, Biological Activity, HPLC.
pH: 7.4
Constituents: 10.26% Trehalose, 0.727% Dibasic monohydrogen potassium phosphate, 0.248% Potassium phosphate monobasic
Purity by HPLC =95%
Receptor for TNFSF2/TNF-alpha and homotrimeric TNFSF1/lymphotoxin-alpha. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Contributes to the induction of non-cytocidal TNF effects including anti-viral state and activation of the acid sphingomyelinase.
The soluble form is produced from the membrane form by proteolytic processing.
This product is an active protein and may elicit a biological response in vivo, handle with caution.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
SDS-PAGE analysis of ab283448.
ESI-TOF analysis of ab283448.
Predicted MW is 20515.11 Da (+/- 10 Da by ESI-TOF). Observed MW is 20517.36 Da.
HPLC analysis of ab283448.
Fully biologically active determined by the dose dependent inhibition of TNF alpha-induced NF-kb activation in mouse RAW264.7 NF-kb luciferase reporter cell line.
ED50 is ≤ 530 ng/ml, corresponding to a specific activity of 1.88 x 103 units/mg.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com